Likewise, Maresca et al. reported an association between hs-cTnI and cardiovascular mortality at 12 months (p < 0.001), though the study involved a small sample and limited adjustment for confounding (age and prior heart disease) [16]. Here, TNNI3 is linked to heart disorder.